US 11661593
Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof
granted A61PA61P7/02A61P9/00
Quick answer
US patent 11661593 (Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof) held by Takeda Pharmaceutical Company Limited expires Mon May 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue May 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61P, A61P7/02, A61P9/00